iPad Screenshots

Description

20-20 Investing is an application to help individuals that invest in pharmaceutical and biotechnology companies to better understand the $500 billion prescription drug market.

Over 150 public drug companies that sell and/or develop over 1,000 prescription drugs that treat over 300 medical conditions are covered in detail within the application.

The easy to use navigational features allow the user to easily track and search what companies make what drugs for what medical conditions.

The free version includes the home page dashboard with stock price % changes for different time periods, upcoming events and links to company stock, drug and financial reports.

The in-app purchase for $4.99/yr will allow the user to gain access to full lists of all covered companies, drugs, medical conditions, quarterly drug revenue and competing drug comparisons.

20-20 Investing is updated daily with the most recent stock price performance, financial results and regulatory changes.

Have 20-20 Investing be your vision into pharmaceutical and biotech investments.

What's New

Version 1.4

Fix IOS 10 content security policy issue

Ratings and Reviews

Best app for investers

Marcustapper

Very good app with great features and options, gives very good insights and analytics., you must give it a try. Go for the premium version its highly recommended.

Great app

Sergey Levchuk

Very useful if you instead in technical analysis!

Information

Seller
Plutus Investments LLC
Size
38.5 MB
Category
Finance
Compatibility
Requires iOS 8.0 or later. Compatible with iPad.
Languages
English
Age Rating
Rated 4+
Copyright
© 2016 20-20 Investing
Price
Free
In-App Purchases
  1. year of premium $4.99

Supports

  • Family Sharing

    With Family Sharing set up, up to six family members can use this app.

You May Also Like